|Articles|June 23, 2022
How Freeze-Thaw Processes Can Be Used for the Commercialization of Cell and Gene Therapy
Author(s)Entegris
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Year in Review: How FDA Guidances Defined the 2025 Biopharma Landscape
2
Biopharma’s 2025 Transformation: A Recap of Our Top 10 Articles
3
AI, CRISPR, and mRNA Driving Biotech’s Smartest Decade Yet
4
Top BP Videos of 2025: An Intersection of AI, Innovation, and Compliance
5